Chinese officials have announced the approval of a COVID-19 vaccine for immediate use by military personnel.
According to UPI. the vaccine, Ad5-nCoV is currently being studied in clinical trials.
There is no word yet on how many of the 2.2 million Chinese military members will receive the vaccine.
Ad5-nCoV was developed by the Beijing Institute of Biotechnology, and biotechnology firm CanSino Biologics.
Globally there have been over 10 million confirmed cases of the novel coronavirus.